APA citiranje

Tenenbaum, A., & Fisman, E. Z. (2004). Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: Fibrates, statins or both? BioMed Central.

Citação norma Chicago

Tenenbaum, Alexander, and Enrique Z. Fisman. Which Is the Best Lipid-modifying Strategy in Metabolic Syndrome and Diabetes: Fibrates, Statins or Both? BioMed Central, 2004.

MLA citiranje

Tenenbaum, Alexander, and Enrique Z. Fisman. Which Is the Best Lipid-modifying Strategy in Metabolic Syndrome and Diabetes: Fibrates, Statins or Both? BioMed Central, 2004.